GlassScriptPhysician profile
Andrija Vidic
NPI 1003120692
$18,278.28
in general payments reported to CMS, 2019-2025
25 companies · $4,174 in 2025
The $4,174 reported for 2025 was more than what a typical Advanced Heart Failure and Transplant Cardiology provider received nationally (typical 2025 total: $1,046).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $86.19 · 2021: $645 · 2022: $1,499 · 2023: $1,953 · 2024: $9,543 · 2025: $4,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,996 · Honoraria: $3,600 · Travel and Lodging: $2,074.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,995.73 |
| Honoraria | $3,600.00 |
| Travel and Lodging | $2,073.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,586.94 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Mitraclip |
| Abiomed | $4,684.77 | 2022-2025 | Impella |
| Cvrx, INC. | $2,476.98 | 2023-2025 | Barostim Neo System |
| Medtronic, INC. | $1,565.37 | 2021-2025 | |
| Paragonix Technologies, INC. | $965.94 | 2022-2024 | Sherpacool Box, Paragonix Sherpapak Cardiac Transport System, Cts Canister Box |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $569.29 | 2021-2024 | Lifevest |
| Impulse Dynamics (USA) INC. | $212.26 | 2023-2024 | Optimizer, Optimizer |
| Briohealth Solutions, INC. | $140.16 | 2025 | Briovad |
| Boston Scientific Corporation | $138.78 | 2023 | Watchman Access System |
| Pfizer INC. | $123.55 | 2019-2025 | |
| Medtronic Vascular, INC. | $110.18 | 2019 | |
| Eurofins Viracor, LLC | $106.75 | 2021 | |
| Novo Nordisk INC | $102.18 | 2022-2025 | Ozempic, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.45 | 2023-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $75.49 | 2022-2023 | Camzyos |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $65.05 | 2021-2023 | Verquvo |
| Kestra Medical Technology Services, INC. | $61.17 | 2024-2025 | Assure Wcd |
| Daiichi Sankyo INC. | $48.49 | 2023-2024 | Injectafer |
| Endotronix, INC. | $32.65 | 2024 | Cordella Pulomonary Artery Pressure Sensor |
| Scpharmaceuticals INC. | $25.70 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.14 | 2025 | |
| One Lambda, INC. | $22.71 | 2021 | |
| Lilly USA, LLC | $20.20 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $19.08 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrija Vidic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.